Statistics

Total Visits

Views
Clinical experience of bosutinib under compasionate use program in chronic myeloid leukemia patients with resistance or intolerance to imatinib, dasatinib and nilotinib69

Select a period of time:

Number of views in the range

Views
Clinical experience of bosutinib under compasionate use program in chronic myeloid leukemia patients with resistance or intolerance to imatinib, dasatinib and nilotinib16

Views

Views
September 20254
October 20255
November 20251
December 20252
January 20262
February 20260
March 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
Germany2
Brazil2
United Kingdom1
Peru1
 

Top cities views

Views
Aracaju1
Ashburn1
Contagem1
Dallas1
Frankfurt am Main1
Lima1
Nuremberg1